Cargando…

The role of (18)F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using (131)I-rituximab as consolidation therapy

PURPOSE: To evaluate the prognostic value of pretreatment (18)F-FDG PET/CT after consolidation therapy of (131)I-rituximab in patients with diffuse large B-cell lymphoma (DLBCL) who had acquired complete remission after receiving chemotherapy. METHODS: Patients who were diagnosed with DLBCL via hist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Joon Ho, Lim, Ilhan, Byun, Byung Hyun, Kim, Byung Il, Choi, Chang Woon, Kang, Hye Jin, Shin, Dong-Yeop, Lim, Sang Moo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512194/ https://www.ncbi.nlm.nih.gov/pubmed/36156599 http://dx.doi.org/10.1371/journal.pone.0273839

Ejemplares similares

Early response monitoring of neoadjuvant chemotherapy using [(18)F]FDG PET can predict the clinical outcome of extremity osteosarcoma
por: Lee, Inki, et al.
Publicado: (2020)

Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
por: Buchegger, Franz, et al.
Publicado: (2011)

Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center (18)F-FDG PET Images
por: Kim, Jingyu, et al.
Publicado: (2021)

Standard Operating Procedure for In-house Preparation of (131)I-rituximab for Radioimmunotherapy of Non-Hodgkin's Lymphoma
por: Pickford, Matthew D., et al.
Publicado: (2012)

Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma
por: Calais, Phillipe J., et al.
Publicado: (2012)

Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma
por: Hwang, Jae Pil, et al.
Publicado: (2016)

Deep Learning-Based Delayed PET Image Synthesis from Corresponding Early Scanned PET for Dosimetry Uptake Estimation
por: Kim, Kangsan, et al.
Publicado: (2023)

Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
por: Choi, Joon Ho, et al.
Publicado: (2020)

Improved Quantification of (18)F-FDG PET during (131)I-Rituximab Therapy on Mouse Lymphoma Models after (131)I Prompt Emission Correction
por: Lee, Young Sub, et al.
Publicado: (2019)

Characteristics of thyroid incidentalomas detected by pre-treatment [(18)F]FDG PET or PET/CT in patients with cervical cancer
por: Lee, Won-Moo, et al.
Publicado: (2012)

Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model
por: Song, In Ho, et al.
Publicado: (2017)

The Prediction of HER2-Targeted Treatment Response Using (64)Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report
por: Lee, Inki, et al.
Publicado: (2022)

Prediction of Chemotherapy Response of Osteosarcoma Using Baseline (18)F-FDG Textural Features Machine Learning Approaches with PCA
por: Jeong, Su Young, et al.
Publicado: (2019)

Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using (18)F-FDG PET/CT, EZRIN, and KI67
por: Kim, Byung-Chul, et al.
Publicado: (2021)

Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
por: Kesavan, Murali, et al.
Publicado: (2017)

Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin’s lymphoma
por: Andemariam, Biree, et al.
Publicado: (2007)

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
por: Park, Hye Lim, et al.
Publicado: (2020)

Combination Radioimmunotherapy Strategies for Solid Tumors
por: Zaheer, Javeria, et al.
Publicado: (2019)

Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer
por: Byun, Byung Hyun, et al.
Publicado: (2013)

The role of histogram analysis of grayscale sonograms to differentiate thyroid nodules identified by (18)F-FDG PET-CT
por: Park, Ko Woon, et al.
Publicado: (2020)

Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics
por: Han, Eun Ji, et al.
Publicado: (2022)

(18)F-FDG PET versus (18)F-FDG PET/CT for Adrenal Gland Lesion Characterization: a Comparison of Diagnostic Efficacy in Lung Cancer Patients
por: Sung, Yon Mi, et al.
Publicado: (2008)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
por: Saiful Alam, A. F.
Publicado: (1991)

Radioimmunotherapy study of (131)I-labeled Atezolizumab in preclinical models of colorectal cancer
por: Zhang, Linhan, et al.
Publicado: (2022)

Measurement of Tumor Pressure and Strategies of Imaging Tumor Pressure for Radioimmunotherapy
por: Kim, Hyeon-gi, et al.
Publicado: (2019)

Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma
por: Choi, Woo Hee, et al.
Publicado: (2023)

Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer
por: Hwang, Jae Pil, et al.
Publicado: (2013)

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
por: Muylle, Kristoff, et al.
Publicado: (2015)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy
por: Tijink, Bernard M., et al.
Publicado: (2009)

Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.
por: Yoneda, S., et al.
Publicado: (1988)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET
por: Kim, Jin Su
Publicado: (2016)

Detection of Recurrence by (18)F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of Disease
por: Ryu, Sang-Young, et al.
Publicado: (2010)

Comparison of (99m)Tc-methyl diphosphonate bone scintigraphy and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma
por: Lee, Inki, et al.
Publicado: (2018)

Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma
por: Burdick, Michael J, et al.
Publicado: (2009)

FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcome
por: Han, Eun Ji, et al.
Publicado: (2016)

Diagnostic accuracy of (18)F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer
por: Choi, Byung Wook, et al.
Publicado: (2016)

A pretargeting system for tumor PET imaging and radioimmunotherapy
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sckheagvk4kj83jjikars5c9u6